Qube Research & Technologies (QRT)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.2M Buy
+640,393
New +$35.2M 0.04% 414
2025
Q1
Sell
-6,576
Closed -$432K 2748
2024
Q4
$432K Buy
+6,576
New +$432K ﹤0.01% 2009
2024
Q3
Sell
-14
Closed -$1.15K 2816
2024
Q2
$1.15K Sell
14
-14,835
-100% -$1.22M ﹤0.01% 2854
2024
Q1
$1.3M Buy
14,849
+4,319
+41% +$377K ﹤0.01% 1693
2023
Q4
$1.02M Sell
10,530
-71,145
-87% -$6.86M ﹤0.01% 1637
2023
Q3
$7.23M Sell
81,675
-407,530
-83% -$36.1M 0.02% 608
2023
Q2
$42.4M Buy
489,205
+12,454
+3% +$1.08M 0.15% 179
2023
Q1
$46.4M Buy
476,751
+211,481
+80% +$20.6M 0.2% 91
2022
Q4
$27.5M Buy
265,270
+169,933
+178% +$17.6M 0.15% 172
2022
Q3
$8.08M Buy
+95,337
New +$8.08M 0.05% 433
2022
Q2
Sell
-268,780
Closed -$20.7M 2506
2022
Q1
$20.7M Buy
+268,780
New +$20.7M 0.18% 140
2021
Q4
Sell
-24,205
Closed -$1.87M 2537
2021
Q3
$1.87M Buy
24,205
+10,252
+73% +$792K 0.02% 699
2021
Q2
$1.16M Buy
13,953
+3,197
+30% +$267K 0.01% 873
2021
Q1
$812K Buy
+10,756
New +$812K 0.01% 931
2020
Q4
Sell
-52,118
Closed -$3.97M 1817
2020
Q3
$3.97M Buy
52,118
+45,906
+739% +$3.49M 0.06% 431
2020
Q2
$766K Buy
+6,212
New +$766K 0.01% 954
2019
Q3
Sell
-6,387
Closed -$547K 262
2019
Q2
$547K Buy
6,387
+2,334
+58% +$200K 0.13% 169
2019
Q1
$360K Buy
+4,053
New +$360K 0.05% 365
2018
Q4
Sell
-2,704
Closed -$262K 363
2018
Q3
$262K Buy
+2,704
New +$262K 0.03% 395